NCT05826808 is a NA clinical trial of Descent to low altitude in Healthy, sponsored by Tsogyal Latshang.

Who is sponsoring NCT05826808?

NCT05826808 is sponsored by Tsogyal Latshang.

What drugs are being tested in NCT05826808?

Interventions in NCT05826808: Descent to low altitude.

Is NCT05826808 still recruiting?

NCT05826808 is currently completed. Last updated 18 February 2026.

Last reviewed 2026-02-18 · How we verify

NCT05826808

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Short-term Descent to Low Altitude in Healthy Residents at Moderate Altitude (>1000 m.a.s.l.).

Completed NA Last updated 18 February 2026

What this trial tests

NA trial testing Descent to low altitude in Healthy in 44 participants. Completed in 16 March 2024.

Timeline

30 June 2023

Primary endpoint
16 March 2024

16 March 2024

Quick facts

Lead sponsor	Tsogyal Latshang
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	diagnostic
Enrollment	44
Start date	30 June 2023
Primary completion	16 March 2024
Estimated completion	16 March 2024
Sites	1 location across Switzerland

Drugs / interventions tested

Descent to low altitude

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Tsogyal Latshang

Who can join

Adults 18 to 70, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the effect of short-term descent in healthy residents at moderate altitude (\>1000 m.a.s.l.).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05826808 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tsogyal Latshang
Last refreshed: 18 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05826808.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing